Trial Profile
In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs KN 002 Kinaset Therapeutics (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 14 Mar 2017 New trial record